November 18, 2013Open Access

Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis

Key Points

Key points are not available for this paper at this time.

Abstract

Renal-artery stenting did not confer a significant benefit with respect to the prevention of clinical events when added to comprehensive, multifactorial medical therapy in people with atherosclerotic renal-artery stenosis and hypertension or chronic kidney disease. (Funded by the National Heart, Lung and Blood Institute and others; ClinicalTrials.gov number, NCT00081731.).

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Cooper et al. (Mon,) studied this question.

synapsesocial.com/papers/69de80297ed287395e55949f https://doi.org/https://doi.org/10.1056/nejmoa1310753

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Renovascular hypertension1997 · 29 citations
2Renal artery stenosis1992 · 463 citations
3Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis1998 · 537 citations
4Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)2001 · 25,997 citations
5Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere.1990 · 331 citations

Bookmark

View Full Paper